-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NptkBxVNtfnjsAglD6jmnXxvBtBOUb2+6MivKjQOUUetlMnGoSrk1Fd1brh/Rdrk jpalM1NFIZE1/RFm4QEFdQ== 0000950133-05-005552.txt : 20051212 0000950133-05-005552.hdr.sgml : 20051212 20051212164937 ACCESSION NUMBER: 0000950133-05-005552 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20051130 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20051212 DATE AS OF CHANGE: 20051212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HUMAN GENOME SCIENCES INC CENTRAL INDEX KEY: 0000901219 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 223178468 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-14169 FILM NUMBER: 051258791 BUSINESS ADDRESS: STREET 1: 14200 SHADY GROVE ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850-3338 BUSINESS PHONE: 3013098504 MAIL ADDRESS: STREET 1: 14200 SHADY GROVE ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850 8-K/A 1 w15575e8vkza.htm FORM 8-K/A e8vkza
 

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K/A
Amendment No. 1
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 30, 2005
HUMAN GENOME SCIENCES, INC.
(Exact name of registrant as specified in its charter)
         
Delaware   0-022962   22-3178468
(State or other jurisdiction
of incorporation) 		  (Commission
File Number) 		  (IRS Employer
Identification No.)
     
14200 Shady Grove Road, Rockville, Maryland   20850-7464
(Address of principal executive offices)   (ZIP Code)
Registrant’s telephone number, including area code: (301) 309-8504
 
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 

Section 5 — Corporate Governance and Management
Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
     As previously reported on the Current Report on Form 8-K filed December 1, 2005, on December 1, 2005, Human Genome Sciences, Inc. (the “Company”) announced that Kathryn Fahlberg has resigned from its Board of Directors, effective November 30, 2005, to devote more time to her other business and personal interests. Also as previously reported on the Current Report on Form 8-K filed December 1, 2005, on December 1, 2005, the Company announced that it has appointed Tuan Ha-Ngoc to fill the vacancy on its Board of Directors created by Ms. Fahlberg’s resignation. Mr. Ha-Ngoc’s appointment to the Company’s Board of Directors is effective as of December 1, 2005. On December 7, 2005, the Company’s Board of Directors appointed Mr. Ha-Ngoc to serve on the Audit Committee of the Company’s Board of Directors.
Section 9 — Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits.
  99.1*   Press Release dated December 1, 2005.
* Incorporated herein by reference to the Company’s Current Report on Form 8-K filed December 1, 2005.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
    HUMAN GENOME SCIENCES, INC.
 
        
    /s/ James H. Davis, Ph.D.
 
  Name:   James H. Davis, Ph.D.
 
  Title:   Executive Vice President, General Counsel
and Secretary
Date: December 12, 2005

 

 

INDEX TO EXHIBITS
     
Exhibit No.
  Description
Exhibit 99.1*
  Press Release dated December 1, 2005.
* Incorporated herein by reference to the Company’s Current Report on Form 8-K filed December 1, 2005.

 

-----END PRIVACY-ENHANCED MESSAGE-----